C07D 513/22
In which the condensed system contains four or more hetero rings
Official title: in which the condensed system contains four or more hetero rings
C07D513/22 (In which the condensed system contains four or more hetero rings) appears on 163 US grants and 252 published applications in this corpus.
Search patents in C07D- Granted patents
- 163
- Published applications
- 252
- Assignees
- 142
- Inventors
- 897
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 8 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 4 |
| 2003 | 2 | 7 |
| 2004 | 3 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 2 |
| 2007 | 4 | 6 |
| 2008 | 3 | 2 |
| 2009 | 1 | 4 |
| 2010 | 1 | 5 |
| 2011 | 2 | 8 |
| 2012 | 4 | 6 |
| 2013 | 3 | 5 |
| 2014 | 4 | 10 |
| 2015 | 4 | 5 |
| 2016 | 12 | 10 |
| 2017 | 7 | 10 |
| 2018 | 6 | 3 |
| 2019 | 3 | 5 |
| 2020 | 4 | 4 |
| 2021 | 4 | 14 |
| 2022 | 4 | 25 |
| 2023 | 10 | 26 |
| 2024 | 14 | 20 |
| 2025 | 20 | 40 |
| 2026 | 9 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic urea orexin receptor agonists21 Jul 2026US 12,686,690 B2Merck Sharp & Dohme Corp.
- Synthesis of amanin and its derivatives16 Jun 2026US 12,655,179 B2Heidelberg Pharma Research GmbH
- Macrocyclic compounds, compositions, and methods of using thereof9 Jun 2026US 12,649,750 B2Genzyme Corporation
- Compound, preparation method thereof, and antibiotic composition comprising same26 May 2026US 12,637,478 B2A & J Science Co., Ltd.
- Macrocyclic compounds, compositions, and methods of using thereof12 May 2026US 12,624,051 B2Genzyme Corporation
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Small molecule glp-1 agonists24 Sep 2026US 2026/0285878 A1Ambrosia Biosciences Inc.
- Macrocyclic compounds, preparation method therefor, and use thereof13 Aug 2026US 2026/0234165 A1Genfleet Therapeutics (Shanghai) Inc.
- Aromatic compound, organic semiconductor layer and organic thin film transistor6 Aug 2026US 2026/0231590 A1Tosoh Corporation
- Compounds comprising heteroaryl rings and compositions and methods thereof30 Jul 2026US 2026/0217697 A1lonGen Therapeutics Co., Ltd.
Most cited
By later US patents
- Rigidized trimethine cyanine dyes103US 6,133,445 ACarnegie Mellon University · 2000
- 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection76US 5,919,779 ABoehringer Ingelheim Pharmaceuticals, Inc. · 1999
- Ecteinascidins40US 5,478,932 AThe Board of Trustees of the University of Illinois · 1995
- Ecteinascidins38US 5,654,426 A1997
- Protein kinase C inhibitors36US 5,624,949 AEli Lilly and Company · 1997